ENTITY

Respiri Ltd (RSH AU)

25
Analysis
Health CareAustralia
Respiri Limited develops and commercializes medical devices. The Company offers wheeze detection devices, inhalers, acoustic sensors, and electronic asthma diaries. as well as renders smartphone applications to detect and measure wheezing and coughing problems. Respiri serves customers worldwide.
more
bullishRespiri Ltd
22 Mar 2024 19:10Issuer-paid

Respiri - Termination of coverage

Edison Investment Research is terminating coverage on Respiri (RSH). Please note you should no longer rely on any previous research or estimates...

Share
bullishRespiri Ltd
13 Sep 2023 19:10Issuer-paid

Respiri - Access platform-led growth prospects ahead

Respiri had a very active FY23, including the recent close of the Access Managed Services (Access) acquisition and the signing of several...

Share
bullishRespiri Ltd
30 Aug 2023 19:10Issuer-paid

Respiri - Early onset of synergies from Access acquisition

Leveraging the expanded scope of operations from its recent acquisition of Access Managed Services (AMS), Respiri has announced the signing of new...

Share
bullishRespiri Ltd
14 Aug 2023 19:10Issuer-paid

Respiri - Raise anticipated to fund the Access acquisition

Following the proposed acquisition of Access Managed Services in May 2023, Respiri announced that it has raised the A$3m as planned as part of the...

Share
bullishRespiri Ltd
17 Jul 2023 15:42Issuer-paid

Respiri - wheezo to access a larger addressable market

Respiri has announced a three-year distribution and marketing agreement (non-exclusive) with Fi-Med Management, a US-based company providing...

Share
x